Publication & Citation Trends
Publications
0 total
Synthesis and Biological Validation of a Harmine-based, Central Nervous System (CNS)-Avoidant, Selective, Human β-Cell Regenerative Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase A (DYRK1A) Inhibitor. OA
Cited by 42
Semantic Scholar
GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human β cell regeneration OA
Cited by 96
Semantic Scholar
Combined Inhibition of DYRK1A, SMAD, and Trithorax Pathways Synergizes to Induce Robust Replication in Adult Human Beta Cells. OA
Cited by 137
Semantic Scholar
Pharmacologic and genetic approaches define human pancreatic beta cell mitogenic targets of DYRK1A inhibitors. OA
Cited by 48
Semantic Scholar
Research Topics
Lipoproteins and Cardiovascular Health
(4)
Pancreatic function and diabetes
(4)
Diabetes Management and Research
(3)
Genetics and Neurodevelopmental Disorders
(3)
Berberine and alkaloids research
(2)
Affiliations
Rutgers, The State University of New Jersey
Brigham and Women's Hospital
Lenox Hill Hospital
United Silicon Carbide (United States)
Knite (United States)